Your browser doesn't support javascript.
loading
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.
Tak, Won Young; Lin, Shi-Ming; Wang, Yijun; Zheng, Jiasheng; Vecchione, Aldo; Park, Soo Young; Chen, Min Hua; Wong, Stephen; Xu, Ruocai; Peng, Cheng-Yuan; Chiou, Yi-You; Huang, Guan-Tarn; Cai, Jianqiang; Abdullah, Basri Johan Jeet; Lee, June Sung; Lee, Jae Young; Choi, Jong-Young; Gopez-Cervantes, Julieta; Sherman, Morris; Finn, Richard S; Omata, Masao; O'Neal, Michael; Makris, Lukas; Borys, Nicholas; Poon, Ronnie; Lencioni, Riccardo.
Afiliación
  • Tak WY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. wytak@knu.ac.kr.
  • Lin SM; Chang Gung Memorial Hospital - Linkou, Taoyuan, Taiwan.
  • Wang Y; Third Central Hospital of Tianjin, Tianjin, China.
  • Zheng J; Beijing You'an Hospital, Capital Medical University, Beijing, China.
  • Vecchione A; National Cancer Institute of Naples, Naples, Italy.
  • Park SY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Chen MH; Peking University Cancer Hospital, Department of Ultrasound, Beijing, China.
  • Wong S; Chinese General Hospital, Manila, Philippines.
  • Xu R; Hunan Cancer Hospital, Department of Hepatobiliary and Pancreatic Internal Medicine, Changsha, China.
  • Peng CY; China Medical University Hospital, Taichung, Taiwan.
  • Chiou YY; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Huang GT; National Taiwan University Hospital, Taipei, Taiwan.
  • Cai J; Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China.
  • Abdullah BJJ; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Lee JS; Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
  • Lee JY; Seoul National University Hospital, Seoul, Republic of Korea.
  • Choi JY; Catholic University of Korea, Seoul, Republic of Korea.
  • Gopez-Cervantes J; St. Luke's Medical Center, Quezon City, Philippines.
  • Sherman M; Toronto General Hospital, Toronto, Ontario, Canada.
  • Finn RS; Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California.
  • Omata M; Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • O'Neal M; BioClinica Inc., Princeton, New Jersey.
  • Makris L; Stathmi, New Hope, Pennsylvania.
  • Borys N; Celsion Corporation, Lawrenceville, New Jersey.
  • Poon R; Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
  • Lencioni R; University of Miami Miller School of Medicine, Section of Vascular and Interventional Radiology, Sylvester Comprehensive Cancer Center, Miami, Florida.
Clin Cancer Res ; 24(1): 73-83, 2018 01 01.
Article en En | MEDLINE | ID: mdl-29018051
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Carcinoma Hepatocelular / Ablación por Radiofrecuencia / Neoplasias Hepáticas / Antibióticos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Carcinoma Hepatocelular / Ablación por Radiofrecuencia / Neoplasias Hepáticas / Antibióticos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article